The FDA said that Sarepta's commercial manufacturing process was not comparable to the process used to make SRP-9001 for early clinical studies. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
